ESPR Accounts Payable
Esperion Therapeutics Inc · Accounts Payable
ESPR Accounts Payable
Latest reported$65.07Mperiod ending
ESPR FY Accounts Payable ($1.43M → $65.07M)
Annual accounts payable
High-resolution chart · PNG
ESPR accounts payable history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accounts Payable (USD) |
|---|---|
| 65,068,000 | |
| 51,650,000 | |
| 31,718,000 | |
| 23,040,000 | |
| 17,559,000 | |
| 51,975,000 | |
| 28,856,000 | |
| 44,893,000 | |
| 20,375,000 | |
| 4,595,000 | |
| 707,000 | |
| 2,040,000 | |
| 2,232,000 | |
| 476,277 | |
| 691,180 | |
| 1,687,000 | |
| 2,925,000 | |
| 3,936,000 | |
| 1,425,000 |